FDA warns of genital gangrene risk with diabetes drug class
Novo’s diabetes pill beats injections in head-to-head trials
J&J seals $2.1bn deal on sale of major diabetes devices firm
A total of 297 employees to be laid off.
As competition hots up, J&J exits insulin pump market
Experimental device requires no user input at all.
Automatic artificial pancreas shows promise in trial
ADA says photo ban is to protect intellectual property.
ADA to re-evaluate tweet ban after backlash